3750.T Stock - ADR120S, Inc.
Unlock GoAI Insights for 3750.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $122.20M | $1.56B | $2.14B | $1.34B | $1.39B |
| Gross Profit | $-55,559,000 | $1.29B | $1.27B | $859.23M | $760.32M |
| Gross Margin | -45.5% | 82.8% | 59.2% | 64.3% | 54.8% |
| Operating Income | $-806,887,000 | $-772,742,000 | $-794,359,000 | $-462,323,000 | $-731,671,000 |
| Net Income | $-2,140,085,999 | $138.16M | $-1,059,941,000 | $-77,633,000 | $-831,863,000 |
| Net Margin | -1751.2% | 8.9% | -49.4% | -5.8% | -59.9% |
| EPS | $-239.70 | $15.44 | $-118.71 | $-8.79 | $-101.64 |
Cytori Cell Research Institute, Inc., engages in the research, development, production, and sale of cell therapy related medical devices in Japan. The company sells cell therapy kits, as well as engages in the research and development of cell therapy technology, etc. Its products pipeline includes ECCI-50 for the treatment of male stress urinary incontinence and liver cirrhosis; and Cyt-006 to prevent postoperative adhesion for primary rectal cancer. The company is also conducting clinical trials/research on cell therapy for a range of diseases and applications, including anterior cruciate ligament repair, bone repair, burn scars, chronic wound healing, critical limb ischemia, anal and Crohn's disease fistulas, erectile dysfunction, etc. It also invests in, owns, develops, leases, and manages real estate projects and hotels; and provides real estate brokerage services. The company was formerly known as FRACTALE Corporation. Cytori Cell Research Institute, Inc. was incorporated in 2004 and is headquartered in Tokyo, Japan.
Visit WebsiteEarnings History & Surprises
3750.TEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-22.50 | — | — |
Q3 2025 | Aug 14, 2025 | — | $7.82 | — | — |
Q2 2025 | May 15, 2025 | — | $-155.53 | — | — |
Q1 2025 | Feb 14, 2025 | — | $-35.75 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-21.26 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-27.16 | — | — |
Q2 2024 | May 14, 2024 | — | $77.37 | — | — |
Q1 2024 | Feb 9, 2024 | — | $-12.24 | — | — |
Q4 2023 | Nov 10, 2023 | — | $-31.59 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-18.07 | — | — |
Q2 2023 | May 12, 2023 | — | $-37.76 | — | — |
Q1 2023 | Feb 10, 2023 | — | $-18.09 | — | — |
Q4 2022 | Nov 11, 2022 | — | $-30.66 | — | — |
Q3 2022 | Aug 10, 2022 | — | $-32.21 | — | — |
Q2 2022 | May 13, 2022 | — | $-15.56 | — | — |
Q1 2022 | Feb 10, 2022 | — | $10.80 | — | — |
Q4 2021 | Nov 10, 2021 | — | $6.73 | — | — |
Q3 2021 | Aug 11, 2021 | — | $-10.69 | — | — |
Q2 2021 | May 14, 2021 | — | $-77.14 | — | — |
Q1 2021 | Feb 10, 2021 | — | $-4.85 | — | — |
Latest News
Frequently Asked Questions about 3750.T
What is 3750.T's current stock price?
What is the analyst price target for 3750.T?
What sector is ADR120S, Inc. in?
What is 3750.T's market cap?
Does 3750.T pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to 3750.T for comparison